<p>Cross Country Healthcare（納斯達克：CCRN - 獲取免費報告）在週一發佈的報告中，Truist Financial 將其目標股價從 10.00 美元上調至 13.25 美元，Benzinga 報道。該券商目前對該商業服務提供商的股票維持 “持有” 評級。Truist Financial 的目標股價表明，相較於股票的前收盤價，存在 0.88% 的潛在上漲空間。</p>
<ul>
<li>在降息前值得購買的前兩隻小型醫療股</li>
</ul>
<p>其他一些股票研究分析師也對 CCRN 發表了看法。Weiss Ratings 在 3 月 27 日的研究報告中重新發布了 Cross Country Healthcare 的 “賣出（e+）” 評級。花旗集團在週四的研究報告中將 Cross Country Healthcare 的評級從 “市場跑贏” 下調至 “市場表現”。Zacks Research 在 1 月 19 日的研究報告中將 Cross Country Healthcare 的評級從 “強烈賣出” 上調至 “持有”。Wedbush 在週四的研究報告中將 Cross Country Healthcare 的評級從 “跑贏大盤” 下調至 “持有”，並將該公司的目標股價從 15.00 美元下調至 13.25 美元。最後，Citizens Jmp 在週四的研究報告中將 Cross Country Healthcare 的評級從 “強烈買入” 下調至 “持有”。九位分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Cross Country Healthcare 目前的平均評級為 “減持”，共識目標股價為 12.72 美元。</p>
<p><strong>閲讀我們關於 CCRN 的最新研究報告</strong></p>
<h2>Cross Country Healthcare 股票下跌 0.3%</h2>
<ul>
<li>這隻小型醫療股表現優於其指數</li>
</ul>
<p>週一中午交易時，納斯達克 CCRN 的股票下跌 0.05 美元，報 13.14 美元。該公司的交易量為 181,468 股，而其平均交易量為 569,250 股。Cross Country Healthcare 的年內最低價為 7.43 美元，年內最高價為 14.99 美元。該公司的 50 日移動平均價格為 9.69 美元，200 日移動平均價格為 9.66 美元。該股票的市值為 4.2295 億美元，市盈率為-4.31，市盈增長比率為 13.87，貝塔值為 0.35。</p>
<p>Cross Country Healthcare（納斯達克：CCRN - 獲取免費報告）最後一次發佈財報是在 5 月 7 日，作為商業服務提供商，該公司報告季度每股收益為（0.03 美元），超出分析師共識預期的（0.05 美元）0.02 美元。Cross Country Healthcare 的股本回報率為-0.74%，淨利潤率為-9.84%。該公司在本季度的收入為 2.4106 億美元，而分析師預期為 2.3707 億美元。整體來看，股票研究分析師預計 Cross Country Healthcare 在當前年度將發佈 0.09 美元的每股收益。</p>
<h2>Cross Country Healthcare 的機構交易</h2>
<p>對沖基金和其他機構投資者最近對該股票的持倉進行了調整。BNP Paribas Financial Markets 在第二季度將其在 Cross Country Healthcare 的股份增加了 50.0%。BNP Paribas Financial Markets 目前擁有 3424 股該商業服務提供商的股票，價值 45,000 美元，此前在上個季度又購買了 1142 股。凱通國際資產管理有限公司在第四季度購買了 Cross Country Healthcare 的新股份，價值約 46,000 美元。Tower Research Capital LLC TRC 在第二季度將其在 Cross Country Healthcare 的股份增加了 422.0%。Tower Research Capital LLC TRC 目前擁有 3586 股該商業服務提供商的股票，價值 47,000 美元，此前在上個季度又購買了 2899 股。Graham Capital Management L.P.在第四季度購買了 Cross Country Healthcare 的新股份，價值約 83,000 美元。最後，AXQ Capital LP 在第四季度購買了 Cross Country Healthcare 的新股份，價值約 109,000 美元。對沖基金和其他機構投資者持有該公司 96.03% 的股票。</p>
<h2>關於 Cross Country Healthcare</h2>
<p>（獲取免費報告）</p>
<p>Cross Country Healthcare, Inc.總部位於佛羅里達州博卡拉頓，是美國領先的醫療勞動力解決方案提供商。該公司專注於護理和相關健康專業人員的招聘、安置和管理，提供旅行和永久性崗位。通過其綜合平台，Cross Country Healthcare 為醫院、健康系統和長期護理設施提供服務，將合格的臨牀人才與不同護理環境中的患者護理需求相匹配。</p>
<p>該公司的核心服務包括旅行護士和相關健康人員的招聘、臨時人員招聘、永久安置服務和管理服務項目。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Cross Country Healthcare</li>
<li>Meta Platforms 的財報後劇烈波動：分析師目標股價現狀</li>
<li>3 只在商品超級週期中表現突出的金屬和礦業股票</li>
<li>捕捉下跌的刀子：現在是購買這些被打壓股票的時候嗎？</li>
<li>星星正在為蘋果對齊：準備迎接 300 美元</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUQI2U3ltYm9sPUNDUk4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUQI2U3ltYm9sPUNDUk4"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Cross Country Healthcare 嗎？</h2>
<p>在考慮 Cross Country Healthcare 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Cross Country Healthcare 並不在名單上。</p>
<p>雖然 Cross Country Healthcare 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

Cross Country醫療保健

標普醫療保健服務 ETF - SPDR

美國醫療保健供應商 ETF - iShares

醫療業 ETF - Vanguard

醫療業 ETF - SPDR

標普全球醫療股指數 ETF - iShares

<p>Truist Financial 已將 Cross Country Healthcare（NASDAQ:CCRN）的目標價從 10.00 美元上調至 13.25 美元，維持 “持有” 評級。這個新目標暗示該股票相較於前一交易日收盤價有 0.88% 的潛在上漲空間。其他分析師的意見各異，Weiss Ratings 給出了 “賣出” 評級，而花旗集團則下調至 “市場表現”。目前，CCRN 的交易價格為 13.14 美元，市值為 4.2295 億美元，市場共識目標價為 12.72 美元</p>

<p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) had its price target hoisted by research analysts at Truist Financial from $10.00 to $13.25 in a report released on Monday,Benzinga reports. The brokerage currently has a &#34;hold&#34; rating on the business services provider's stock. Truist Financial's price objective points to a potential upside of 0.88% from the stock's previous close.</p>
<div class="lb-trans"><p>Cross Country Healthcare（納斯達克：CCRN - 獲取免費報告）在週一發佈的報告中，Truist Financial 將其目標股價從 10.00 美元上調至 13.25 美元，Benzinga 報道。該券商目前對該商業服務提供商的股票維持 “持有” 評級。Truist Financial 的目標股價表明，相較於股票的前收盤價，存在 0.88% 的潛在上漲空間。</p>
</div><ul>
<li>Top 2 Small Cap Healthcare Stocks to Buy Before Rate Cuts</li>
</ul>
<div class="lb-trans"><ul>
<li>在降息前值得購買的前兩隻小型醫療股</li>
</ul>
</div><p>A number of other equities research analysts have also weighed in on CCRN. Weiss Ratings reissued a &#34;sell (e+)&#34; rating on shares of Cross Country Healthcare in a research note on Friday, March 27th. Citigroup lowered Cross Country Healthcare from a &#34;market outperform&#34; rating to a &#34;market perform&#34; rating in a research note on Thursday. Zacks Research raised Cross Country Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, January 19th. Wedbush lowered Cross Country Healthcare from an &#34;outperform&#34; rating to a &#34;hold&#34; rating and lowered their price target for the company from $15.00 to $13.25 in a research report on Thursday. Finally, Citizens Jmp lowered Cross Country Healthcare from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday. Nine analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Cross Country Healthcare presently has an average rating of &#34;Reduce&#34; and a consensus price target of $12.72.</p>
<div class="lb-trans"><p>其他一些股票研究分析師也對 CCRN 發表了看法。Weiss Ratings 在 3 月 27 日的研究報告中重新發布了 Cross Country Healthcare 的 “賣出（e+）” 評級。花旗集團在週四的研究報告中將 Cross Country Healthcare 的評級從 “市場跑贏” 下調至 “市場表現”。Zacks Research 在 1 月 19 日的研究報告中將 Cross Country Healthcare 的評級從 “強烈賣出” 上調至 “持有”。Wedbush 在週四的研究報告中將 Cross Country Healthcare 的評級從 “跑贏大盤” 下調至 “持有”，並將該公司的目標股價從 15.00 美元下調至 13.25 美元。最後，Citizens Jmp 在週四的研究報告中將 Cross Country Healthcare 的評級從 “強烈買入” 下調至 “持有”。九位分析師對該股票給予了 “持有” 評級，一位分析師給予了 “賣出” 評級。根據 MarketBeat.com 的數據，Cross Country Healthcare 目前的平均評級為 “減持”，共識目標股價為 12.72 美元。</p>
</div><p><strong>Read Our Latest Research Report on CCRN</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 CCRN 的最新研究報告</strong></p>
</div><h2>Cross Country Healthcare Stock Down 0.3%</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 股票下跌 0.3%</h2>
</div><ul>
<li>This Small-Cap Healthcare Name Is Outperforming Its Index</li>
</ul>
<div class="lb-trans"><ul>
<li>這隻小型醫療股表現優於其指數</li>
</ul>
</div><p>Shares of NASDAQ CCRN traded down $0.05 during midday trading on Monday, reaching $13.14. The company had a trading volume of 181,468 shares, compared to its average volume of 569,250. Cross Country Healthcare has a one year low of $7.43 and a one year high of $14.99. The firm's fifty day moving average price is $9.69 and its 200-day moving average price is $9.66. The stock has a market cap of $422.95 million, a PE ratio of -4.31, a price-to-earnings-growth ratio of 13.87 and a beta of 0.35.</p>
<div class="lb-trans"><p>週一中午交易時，納斯達克 CCRN 的股票下跌 0.05 美元，報 13.14 美元。該公司的交易量為 181,468 股，而其平均交易量為 569,250 股。Cross Country Healthcare 的年內最低價為 7.43 美元，年內最高價為 14.99 美元。該公司的 50 日移動平均價格為 9.69 美元，200 日移動平均價格為 9.66 美元。該股票的市值為 4.2295 億美元，市盈率為-4.31，市盈增長比率為 13.87，貝塔值為 0.35。</p>
</div><p>Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last released its earnings results on Thursday, May 7th. The business services provider reported ($0.03) earnings per share for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. Cross Country Healthcare had a negative return on equity of 0.74% and a negative net margin of 9.84%.The company had revenue of $241.06 million during the quarter, compared to analyst estimates of $237.07 million. As a group, equities research analysts expect that Cross Country Healthcare will post 0.09 EPS for the current year.</p>
<div class="lb-trans"><p>Cross Country Healthcare（納斯達克：CCRN - 獲取免費報告）最後一次發佈財報是在 5 月 7 日，作為商業服務提供商，該公司報告季度每股收益為（0.03 美元），超出分析師共識預期的（0.05 美元）0.02 美元。Cross Country Healthcare 的股本回報率為-0.74%，淨利潤率為-9.84%。該公司在本季度的收入為 2.4106 億美元，而分析師預期為 2.3707 億美元。整體來看，股票研究分析師預計 Cross Country Healthcare 在當前年度將發佈 0.09 美元的每股收益。</p>
</div><h2>Institutional Trading of Cross Country Healthcare</h2>
<div class="lb-trans"><h2>Cross Country Healthcare 的機構交易</h2>
</div><p>Hedge funds and other institutional investors have recently made changes to their positions in the stock. BNP Paribas Financial Markets grew its stake in shares of Cross Country Healthcare by 50.0% in the 2nd quarter. BNP Paribas Financial Markets now owns 3,424 shares of the business services provider's stock worth $45,000 after buying an additional 1,142 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $46,000. Tower Research Capital LLC TRC grew its stake in shares of Cross Country Healthcare by 422.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,586 shares of the business services provider's stock worth $47,000 after buying an additional 2,899 shares during the last quarter. Graham Capital Management L.P. purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $83,000. Finally, AXQ Capital LP purchased a new stake in shares of Cross Country Healthcare in the 4th quarter worth approximately $109,000. Hedge funds and other institutional investors own 96.03% of the company's stock.</p>
<div class="lb-trans"><p>對沖基金和其他機構投資者最近對該股票的持倉進行了調整。BNP Paribas Financial Markets 在第二季度將其在 Cross Country Healthcare 的股份增加了 50.0%。BNP Paribas Financial Markets 目前擁有 3424 股該商業服務提供商的股票，價值 45,000 美元，此前在上個季度又購買了 1142 股。凱通國際資產管理有限公司在第四季度購買了 Cross Country Healthcare 的新股份，價值約 46,000 美元。Tower Research Capital LLC TRC 在第二季度將其在 Cross Country Healthcare 的股份增加了 422.0%。Tower Research Capital LLC TRC 目前擁有 3586 股該商業服務提供商的股票，價值 47,000 美元，此前在上個季度又購買了 2899 股。Graham Capital Management L.P.在第四季度購買了 Cross Country Healthcare 的新股份，價值約 83,000 美元。最後，AXQ Capital LP 在第四季度購買了 Cross Country Healthcare 的新股份，價值約 109,000 美元。對沖基金和其他機構投資者持有該公司 96.03% 的股票。</p>
</div><h2>About Cross Country Healthcare</h2>
<div class="lb-trans"><h2>關於 Cross Country Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.</p>
<div class="lb-trans"><p>Cross Country Healthcare, Inc.總部位於佛羅里達州博卡拉頓，是美國領先的醫療勞動力解決方案提供商。該公司專注於護理和相關健康專業人員的招聘、安置和管理，提供旅行和永久性崗位。通過其綜合平台，Cross Country Healthcare 為醫院、健康系統和長期護理設施提供服務，將合格的臨牀人才與不同護理環境中的患者護理需求相匹配。</p>
</div><p>The company's core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.</p>
<div class="lb-trans"><p>該公司的核心服務包括旅行護士和相關健康人員的招聘、臨時人員招聘、永久安置服務和管理服務項目。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Cross Country Healthcare</li>
<li>Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand Now</li>
<li>3 Metals and Mining Stocks Riding the Commodity Supercycle</li>
<li>Catching Falling Knives: Is Time to Buy These Beaten-Down Stocks?</li>
<li>The Stars Are Aligning For Apple: Get Ready for $300</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Cross Country Healthcare</li>
<li>Meta Platforms 的財報後劇烈波動：分析師目標股價現狀</li>
<li>3 只在商品超級週期中表現突出的金屬和礦業股票</li>
<li>捕捉下跌的刀子：現在是購買這些被打壓股票的時候嗎？</li>
<li>星星正在為蘋果對齊：準備迎接 300 美元</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0NSTg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=CCRN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Cross Country Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Cross Country Healthcare 嗎？</h2>
</div><p>Before you consider Cross Country Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Cross Country Healthcare 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前購買……而 Cross Country Healthcare 並不在名單上。</p>
</div><p>While Cross Country Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Cross Country Healthcare 目前在分析師中被評為減持，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Cross Country Healthcare (NASDAQ:CCRN) Price Target Raised to $13.25 at Truist Financial

Market Beat

Truist Financial

花旗

Citizens Financial

法國巴黎銀行(ADR)

CITIGROUP INC 6.250 NON CUM SER II PFD WI

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

Cross Country 醫療保健（納斯達克代碼：CCRN）的目標價在 Truist Financial 被上調至 13.25 美元